FDA Releases 2019 NARMS Report
The U.S. Food and Drug Administration released the summary of the 2019 National Antimicrobial Resistance Monitoring System (NARMS) report on Monday.
NARMS is a national public health surveillance system that monitors enteric bacteria and select animal pathogens to determine if they are resistant to antimicrobial agents used in human and veterinary medicine.
Specifically, NARMS monitors antibiotic resistance among the following four major foodborne bacteria: Salmonella, Campylobacter, Escherichia coli, and Enterococcus.
The resulting information and data are then used by FDA in the regulatory review of new animal antimicrobial drugs, and to develop policies on judicious antimicrobial use in animals.
One of the things that’s new in this particular report is how multidrug resistance (MDR) is being calculated.
NARMS is a collaboration of agencies within the U.S. Department of Health and Human Services: Food and Drug Administration, Centers for Disease Control and Prevention and the U.S. Department of Agriculture Food Safety and Inspection Service, Animal and Plant Health Inspection Service, and the Agricultural Research Service.
More information is available here: NARMS Integrated Summary 2019
